4
Changes in Ownership
Roivant Sciences Ltd. Filed Acc 0001635088-26-000019
President and Vant Chair sold 3,000,000 shares at an average $27.35 ($82,039,460)
- President and Vant Chair acquired 3,000,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Torti Frank · President and Vant Chair
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-02-19 | Exercise or conversion : show line 1 in the form 10b5-1 | +1,400,000 | $3.85 | $5,390,000 | 15,136,547 | D |
| 2026-02-19 | Sale : show line 2 in the form 10b5-1 | −1,400,000 | $27.42 | $38,388,000 | 13,736,547 | D |
| 2026-02-20 | Exercise or conversion : show line 3 in the form 10b5-1 | +1,012,610 | $3.85 | $3,898,549 | 14,749,157 | D |
| 2026-02-20 | Sale : show line 4 in the form 10b5-1 | −1,012,610 | $27.15 | $27,492,362 | 13,736,547 | D |
| 2026-02-23 | Exercise or conversion : show line 5 in the form 10b5-1 | +587,390 | $3.85 | $2,261,452 | 14,323,937 | D |
| 2026-02-23 | Sale : show line 6 in the form 10b5-1 | −587,390 | $27.51 | $16,159,099 | 13,736,547 | D |
| Open-market sales · 3,000,000 sh · avg $27.35 · $82,039,460 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-02-19 | Exercise or conversion : show line 7 in the form 10b5-1 Stock Option (Right to Buy) | −1,400,000 | 4,626,184 | D |
| 2026-02-20 | Exercise or conversion : show line 8 in the form 10b5-1 Stock Option (Right to Buy) | −1,012,610 | 3,613,574 | D |
| 2026-02-23 | Exercise or conversion : show line 9 in the form 10b5-1 Stock Option (Right to Buy) | −587,390 | 3,026,184 | D |
Loading xslF345X05/wk-form4_1771897216.xml…